Supplementary Figure S2 from Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22–00
crossref(2023)
摘要
Kaplan-Meier estimates for OS, DFS, DRFI and BCFI measures according to CM maintenance.
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要